Trial of COVID-19 blood plasma finds no benefit in severely ill patients – Reuters

Trial of COVID-19 blood plasma finds no benefit in severely ill patients – Reuters

An international trial testing convalescent blood plasma on COVID-19 patients with moderate and severe illness has halted enrolment of severely ill COVID-19 patients requiring intensive care after it found no benefit, trial investigators said on Monday.

Read More…

You May Also Like